Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course
- Study Title
- A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course
- Teva Identifier
- MS-LAQ-301E | 2009-012989-30
- ClinicalTrials.gov Identifier
- NCT00988052
- Study Status
- Terminated
- Trial Condition(s)
- Relapsing Multiple Sclerosis
- Interventions
- Drug: Laquinimod
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- November 10, 2009 - July 1, 2017
- Phase
- Phase 3
